Loading…

Marrow Transplantation in the Treatment of a Murine Heritable Hemolytic Anemia

Mice with hemolytic anemia, sphha/sphha, have extremely fragile RBCs with a lifespan of approximately one day. Neither splenectomy nor simple transplantation of normal marrow after lethal irradiation cures the anemia but instead causes rapid deterioration and death of the mutant unless additional pr...

Full description

Saved in:
Bibliographic Details
Published in:Blood 1989-05, Vol.73 (7), p.2014-2017
Main Authors: Barker, Jane E., McFarland-Starr, Eleanor C.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c368t-c18d70f8cf1c24334c03fe5cdbd6d1661265d1b5aa0253845c701d35695b4dfd3
cites
container_end_page 2017
container_issue 7
container_start_page 2014
container_title Blood
container_volume 73
creator Barker, Jane E.
McFarland-Starr, Eleanor C.
description Mice with hemolytic anemia, sphha/sphha, have extremely fragile RBCs with a lifespan of approximately one day. Neither splenectomy nor simple transplantation of normal marrow after lethal irradiation cures the anemia but instead causes rapid deterioration and death of the mutant unless additional prophylactic procedures are used. In this report, we show that normal marrow transplantation preceded by sublethal irradiation increases but does not normalize RBC count. The mutant RBCs but not all the WBCs are replaced by donor cells. Splenectomy of the improved recipient causes a dramatic decrease in RBC count, indicating that the mutant spleen is a site of donor-origin erythropoiesis as well as of RBC destruction. Injections of iron dextran did not improve RBC counts. Transplantation of primary recipient marow cells into a secondary host with a heritable stem cell deficiency (W/ Wv) corrects the defect caused by residence of the normal cells in the sphha/sphha host. The original + / + donor cells replace the RBCs of the secondary host, and the RBC count is normalized. Results indicate that the environment in the sphha/sphha host is detrimental to normal (as well as mutant) erythroid cells but the restriction is not transmitted.
doi_str_mv 10.1182/blood.V73.7.2014.2014
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78964503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120755217</els_id><sourcerecordid>78964503</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-c18d70f8cf1c24334c03fe5cdbd6d1661265d1b5aa0253845c701d35695b4dfd3</originalsourceid><addsrcrecordid>eNqFkMlOwzAQQC0EgrJ8AlIOiFuK96QnVCGgSC1cgKvl2BNhlMTFdkH9e9xFXLmMLc-bxQ-hS4LHhNT0pum8t-P3io2rMcWEb8MBGhFB6xJjig_RCGMsSz6pyAk6jfETZ4JRcYyOqRSMy3qEnhc6BP9TvAY9xGWnh6ST80PhhiJ9QH4GnXoYUuHbQheLVXADFDMILumm29x6362TM8V0gN7pc3TU6i7Cxf48Q28P9693s3L-8vh0N52Xhsk6lYbUtsJtbVpiKGeMG8xaEMY2VloiJcn7WdIIrTEVrObCVJhYJuRENNy2lp2h613fZfBfK4hJ9S4a6PIHwK-iquqJ5AKzDIodaIKPMUCrlsH1OqwVwWrjUW09quxRVWqjcBty3eV-wKrpwf5V7cXl_NU-r6PRXZv1GRf_sIpSzCebNrc7DLKMbwdBReNgMGBdAJOU9e6fRX4ByCqRjQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78964503</pqid></control><display><type>article</type><title>Marrow Transplantation in the Treatment of a Murine Heritable Hemolytic Anemia</title><source>ScienceDirect</source><creator>Barker, Jane E. ; McFarland-Starr, Eleanor C.</creator><creatorcontrib>Barker, Jane E. ; McFarland-Starr, Eleanor C.</creatorcontrib><description>Mice with hemolytic anemia, sphha/sphha, have extremely fragile RBCs with a lifespan of approximately one day. Neither splenectomy nor simple transplantation of normal marrow after lethal irradiation cures the anemia but instead causes rapid deterioration and death of the mutant unless additional prophylactic procedures are used. In this report, we show that normal marrow transplantation preceded by sublethal irradiation increases but does not normalize RBC count. The mutant RBCs but not all the WBCs are replaced by donor cells. Splenectomy of the improved recipient causes a dramatic decrease in RBC count, indicating that the mutant spleen is a site of donor-origin erythropoiesis as well as of RBC destruction. Injections of iron dextran did not improve RBC counts. Transplantation of primary recipient marow cells into a secondary host with a heritable stem cell deficiency (W/ Wv) corrects the defect caused by residence of the normal cells in the sphha/sphha host. The original + / + donor cells replace the RBCs of the secondary host, and the RBC count is normalized. Results indicate that the environment in the sphha/sphha host is detrimental to normal (as well as mutant) erythroid cells but the restriction is not transmitted.</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood.V73.7.2014.2014</identifier><identifier>PMID: 2653468</identifier><language>eng</language><publisher>Washington, DC: Elsevier Inc</publisher><subject>Anemia, Hemolytic, Congenital - blood ; Anemia, Hemolytic, Congenital - genetics ; Anemia, Hemolytic, Congenital - surgery ; Anemias. Hemoglobinopathies ; Animals ; Biological and medical sciences ; Bone Marrow - pathology ; Bone Marrow - radiation effects ; Bone Marrow Transplantation ; Diseases of red blood cells ; Erythrocyte Count - radiation effects ; Glucose-6-Phosphate Isomerase - blood ; Glucose-6-Phosphate Isomerase - genetics ; Hematologic and hematopoietic diseases ; Hematopoietic Stem Cells - pathology ; Male ; Medical sciences ; Mice ; Mice, Mutant Strains - blood ; Phenotype ; Postoperative Complications - blood ; Postoperative Complications - pathology ; Radiation Chimera</subject><ispartof>Blood, 1989-05, Vol.73 (7), p.2014-2017</ispartof><rights>1989 American Society of Hematology</rights><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-c18d70f8cf1c24334c03fe5cdbd6d1661265d1b5aa0253845c701d35695b4dfd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006497120755217$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27901,27902,45756</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7220494$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2653468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barker, Jane E.</creatorcontrib><creatorcontrib>McFarland-Starr, Eleanor C.</creatorcontrib><title>Marrow Transplantation in the Treatment of a Murine Heritable Hemolytic Anemia</title><title>Blood</title><addtitle>Blood</addtitle><description>Mice with hemolytic anemia, sphha/sphha, have extremely fragile RBCs with a lifespan of approximately one day. Neither splenectomy nor simple transplantation of normal marrow after lethal irradiation cures the anemia but instead causes rapid deterioration and death of the mutant unless additional prophylactic procedures are used. In this report, we show that normal marrow transplantation preceded by sublethal irradiation increases but does not normalize RBC count. The mutant RBCs but not all the WBCs are replaced by donor cells. Splenectomy of the improved recipient causes a dramatic decrease in RBC count, indicating that the mutant spleen is a site of donor-origin erythropoiesis as well as of RBC destruction. Injections of iron dextran did not improve RBC counts. Transplantation of primary recipient marow cells into a secondary host with a heritable stem cell deficiency (W/ Wv) corrects the defect caused by residence of the normal cells in the sphha/sphha host. The original + / + donor cells replace the RBCs of the secondary host, and the RBC count is normalized. Results indicate that the environment in the sphha/sphha host is detrimental to normal (as well as mutant) erythroid cells but the restriction is not transmitted.</description><subject>Anemia, Hemolytic, Congenital - blood</subject><subject>Anemia, Hemolytic, Congenital - genetics</subject><subject>Anemia, Hemolytic, Congenital - surgery</subject><subject>Anemias. Hemoglobinopathies</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Bone Marrow - pathology</subject><subject>Bone Marrow - radiation effects</subject><subject>Bone Marrow Transplantation</subject><subject>Diseases of red blood cells</subject><subject>Erythrocyte Count - radiation effects</subject><subject>Glucose-6-Phosphate Isomerase - blood</subject><subject>Glucose-6-Phosphate Isomerase - genetics</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hematopoietic Stem Cells - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Mutant Strains - blood</subject><subject>Phenotype</subject><subject>Postoperative Complications - blood</subject><subject>Postoperative Complications - pathology</subject><subject>Radiation Chimera</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><recordid>eNqFkMlOwzAQQC0EgrJ8AlIOiFuK96QnVCGgSC1cgKvl2BNhlMTFdkH9e9xFXLmMLc-bxQ-hS4LHhNT0pum8t-P3io2rMcWEb8MBGhFB6xJjig_RCGMsSz6pyAk6jfETZ4JRcYyOqRSMy3qEnhc6BP9TvAY9xGWnh6ST80PhhiJ9QH4GnXoYUuHbQheLVXADFDMILumm29x6362TM8V0gN7pc3TU6i7Cxf48Q28P9693s3L-8vh0N52Xhsk6lYbUtsJtbVpiKGeMG8xaEMY2VloiJcn7WdIIrTEVrObCVJhYJuRENNy2lp2h613fZfBfK4hJ9S4a6PIHwK-iquqJ5AKzDIodaIKPMUCrlsH1OqwVwWrjUW09quxRVWqjcBty3eV-wKrpwf5V7cXl_NU-r6PRXZv1GRf_sIpSzCebNrc7DLKMbwdBReNgMGBdAJOU9e6fRX4ByCqRjQ</recordid><startdate>19890515</startdate><enddate>19890515</enddate><creator>Barker, Jane E.</creator><creator>McFarland-Starr, Eleanor C.</creator><general>Elsevier Inc</general><general>The Americain Society of Hematology</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19890515</creationdate><title>Marrow Transplantation in the Treatment of a Murine Heritable Hemolytic Anemia</title><author>Barker, Jane E. ; McFarland-Starr, Eleanor C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-c18d70f8cf1c24334c03fe5cdbd6d1661265d1b5aa0253845c701d35695b4dfd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Anemia, Hemolytic, Congenital - blood</topic><topic>Anemia, Hemolytic, Congenital - genetics</topic><topic>Anemia, Hemolytic, Congenital - surgery</topic><topic>Anemias. Hemoglobinopathies</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Bone Marrow - pathology</topic><topic>Bone Marrow - radiation effects</topic><topic>Bone Marrow Transplantation</topic><topic>Diseases of red blood cells</topic><topic>Erythrocyte Count - radiation effects</topic><topic>Glucose-6-Phosphate Isomerase - blood</topic><topic>Glucose-6-Phosphate Isomerase - genetics</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hematopoietic Stem Cells - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Mutant Strains - blood</topic><topic>Phenotype</topic><topic>Postoperative Complications - blood</topic><topic>Postoperative Complications - pathology</topic><topic>Radiation Chimera</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barker, Jane E.</creatorcontrib><creatorcontrib>McFarland-Starr, Eleanor C.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barker, Jane E.</au><au>McFarland-Starr, Eleanor C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Marrow Transplantation in the Treatment of a Murine Heritable Hemolytic Anemia</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>1989-05-15</date><risdate>1989</risdate><volume>73</volume><issue>7</issue><spage>2014</spage><epage>2017</epage><pages>2014-2017</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>Mice with hemolytic anemia, sphha/sphha, have extremely fragile RBCs with a lifespan of approximately one day. Neither splenectomy nor simple transplantation of normal marrow after lethal irradiation cures the anemia but instead causes rapid deterioration and death of the mutant unless additional prophylactic procedures are used. In this report, we show that normal marrow transplantation preceded by sublethal irradiation increases but does not normalize RBC count. The mutant RBCs but not all the WBCs are replaced by donor cells. Splenectomy of the improved recipient causes a dramatic decrease in RBC count, indicating that the mutant spleen is a site of donor-origin erythropoiesis as well as of RBC destruction. Injections of iron dextran did not improve RBC counts. Transplantation of primary recipient marow cells into a secondary host with a heritable stem cell deficiency (W/ Wv) corrects the defect caused by residence of the normal cells in the sphha/sphha host. The original + / + donor cells replace the RBCs of the secondary host, and the RBC count is normalized. Results indicate that the environment in the sphha/sphha host is detrimental to normal (as well as mutant) erythroid cells but the restriction is not transmitted.</abstract><cop>Washington, DC</cop><pub>Elsevier Inc</pub><pmid>2653468</pmid><doi>10.1182/blood.V73.7.2014.2014</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 1989-05, Vol.73 (7), p.2014-2017
issn 0006-4971
1528-0020
language eng
recordid cdi_proquest_miscellaneous_78964503
source ScienceDirect
subjects Anemia, Hemolytic, Congenital - blood
Anemia, Hemolytic, Congenital - genetics
Anemia, Hemolytic, Congenital - surgery
Anemias. Hemoglobinopathies
Animals
Biological and medical sciences
Bone Marrow - pathology
Bone Marrow - radiation effects
Bone Marrow Transplantation
Diseases of red blood cells
Erythrocyte Count - radiation effects
Glucose-6-Phosphate Isomerase - blood
Glucose-6-Phosphate Isomerase - genetics
Hematologic and hematopoietic diseases
Hematopoietic Stem Cells - pathology
Male
Medical sciences
Mice
Mice, Mutant Strains - blood
Phenotype
Postoperative Complications - blood
Postoperative Complications - pathology
Radiation Chimera
title Marrow Transplantation in the Treatment of a Murine Heritable Hemolytic Anemia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T19%3A36%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Marrow%20Transplantation%20in%20the%20Treatment%20of%20a%20Murine%20Heritable%20Hemolytic%20Anemia&rft.jtitle=Blood&rft.au=Barker,%20Jane%20E.&rft.date=1989-05-15&rft.volume=73&rft.issue=7&rft.spage=2014&rft.epage=2017&rft.pages=2014-2017&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood.V73.7.2014.2014&rft_dat=%3Cproquest_cross%3E78964503%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c368t-c18d70f8cf1c24334c03fe5cdbd6d1661265d1b5aa0253845c701d35695b4dfd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78964503&rft_id=info:pmid/2653468&rfr_iscdi=true